Log in or Sign up for Free to view tailored content for your specialty!
Depression News
Most adults with diabetes report emotional distress, but do not discuss it with care team
The majority of adults with diabetes say their diabetes team has never discussed the topic of mental health with them, even though most self-reported feelings of emotional distress, according to survey data published in Diabetic Medicine.
World Mental Health Day: Hidden burdens of skin disease include stigmatization
Each year, WHO marks World Mental Health Day on Oct. 10 in an effort to raise awareness of mental health issues around the world and mobilize efforts to support mental health.
Log in or Sign up for Free to view tailored content for your specialty!
WHO demands accessible, quality care for World Mental Health Day
Mental health conditions affect one in eight people and one in seven adolescents worldwide, according to WHO.
Depression screening needed when patients experience sudden vision loss
I did not serve as a physician in the military.
Study finds no associations between various mental health conditions and results after TJA
Published results showed no statistically significant associations between mental health conditions, such as depression, anxiety, bipolar disorder, trauma and schizophrenia, and outcomes after total joint arthroplasty.
Positive results announced in phase 2 trial of intranasal ketamine for adults with MDD
A Manhattan-based biopharmaceutical firm has announced positive topline data from its phase 2 trial of a novel formulation of intranasal racemic ketamine for acute suicidal ideation and behavior in adults with major depressive disorder.
FDA approves antidepressant not linked to sexual dysfunction, weight gain
The FDA has approved Exxua, an oral selective 5HT1a receptor agonist for the treatment of major depressive disorder in adults.
High intake of artificially sweetened drinks associated with higher depression risk
Increased intake of ultraprocessed foods, especially artificially sweetened beverages and artificial sweeteners, was linked to a high risk for depression, according to the results of research published in JAMA Network Open.
Biotech firm receives patent for psilocybin-derived mental health therapeutics
A Boston-area biotechnology firm announced it has received a patent titled “Carboxylated Psilocybin Derivatives and Methods of Using” for its EVM301 series of molecules to treat a range of mental health disorders.
Biomarker tracks depression recovery after deep brain stimulation
A small study of patients with treatment-resistant depression identified a brain-based biomarker of recovery following deep brain stimulation of the subcallosal cingulate.
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read